I

InMed Pharmaceuticals

INM

0.17940
USD
0.0038
(2.16%)
مغلق
حجم التداول
27,939
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
2,711,363
الأخبار المقالات

العنوان: InMed Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.